D tumoroid models transform cancer research, accurately reflecting tumor biology and enabling effective drug testing and ...

Mayo Clinic's organoids, microscopic versions of organs that function like the real ones, have been used by doctors to study ...

Mayo Clinic researchers have developed organoid models to study uveal melanoma, one of the most common types of eye cancer in ...

Mayo Clinic researchers have developed organoid models to study uveal melanoma, one of the most common types of eye cancer in ...

ROCHESTER, Minnesota — Mayo Clinic researchers have developed  organoid models  to study  uveal melanoma , one of the most common types of eye cancer ...

Mayo Clinic researchers have developed organoid models to study uveal melanoma, one of the most common types of eye cancer in adults. Their goal is to use these models to better understand how this ...

Okomera is a biotech startup developing cutting-edge solutions for oncology drug discovery and will present their technology in SLAS 2025,in San Diego January 25 to 29, 2025. Okomera will showcase its ...

The age of targeted cancer therapies brings the potential for more treatment options, greater effectiveness and fewer side ...

Induces potent and long-lasting immune responses to defined antigens or whole pathogens (particles), mainly through the ...

Brain organoids developed in Israel for testing and repurposing a wide variety of existing drugs to see if they could treat ...

Experience the power of CHIMERA, the modular biofabrication platform from Ourobionics that sets a new standard in regenerative medicine.

Bioinformatics allowed me to address these questions faster and with a broader perspective. The growing availability of public data facilitated this. However, the transition wasn’t easy. I tried many ...